D0391 - Inflammatory Bowel Disease Is a Strong Predictor of Central Line-Associated Blood Stream Infections in Patients Admitted to the ICU

Mohammad Darweesh, MD¹, Rasheed Musa, MD¹, Ratib Mahfouz, MD², Mahmoud Mansour, MD³, Adham E. Obeidat, MBBS⁴, Usama Abu-Heija, MBBS¹, Chakradhar Reddy, MD^1
1East Tennessee State University, Johnson City, TN; ²Brown University/Kent Hospital, Providence, RI; ³University of Missouri Columbia, Columbia, MO; ⁴University of Hawaii, Honolulu, HI

Introduction: Inflammatory bowel disease (IBD) course can be complicated with ICU admission and central line placement for different reasons. One of the common complications of central line placement is central line-associated bloodstream infections (CLABSI).

Methods: A retrospective study was conducted utilizing the Nationwide Inpatient Sample database (NIS) for the years 2016 to 2018. Patients with CLABSI and IBD were identified using ICD 10 diagnosis codes from all listed discharge diagnoses. Patients younger than 18 years of age, and missing information for age, gender, or race were excluded. ICU admission was defined by the presence of vasopressors or mechanical ventilation. Multivariate logistic regression analysis was performed to compare different risk factors in predicting CLABSI.

Results: 3,196,820 patients were included in this study, of those; 7924 (0.24%) had CLABSI. This study reports that adults admitted to the ICU had increased odds of developing CLABSI by three and a half times when they had IBD (OR 3.51, P-value 0.00, 95% CI 2.61-4.70), six times when they had bone marrow transplant (OR 6.10, P-value 0.00, 95% CI 3.49-10.65), and five times when they had neutropenia (OR 5.31, P-value 0.00, 95% CI 4.19-6.72), all were statistically significant. Upon subdividing patients with IBD into Crohn’s disease (CD) and ulcerative colitis (UC), we found that patients with CD tend to have high odds of developing CLABSI with OR of 4.61 (P-value 0.00, 95% CI 3.29-6.47) compared to patients with UC who had OR of 2.04 (P-value 0.02, 95% CI 1.15-3.62) and both were statistically significant.

Discussion: This study demonstrates high odds of CLABSI in IBD patients admitted to the ICU compared to patients without such a history. This result can be explained by multiple factors. The fact that patients with IBD are usually treated with immune suppressants can result in a higher incidence of infections including CLABSI. Other etiologies might also include total parenteral nutrition (TPN), as patients with IBD may require TPN as part of their nutritional support while in the ICU. After subdividing patients with IBD into CD and UC, the odds of encountering CLABS tend to be higher in CD, no clear etiology for this finding was found, however, it can be secondary to the transmural involvement of the intestinal wall in CD compared to the submucosal involvement in UC.



Disclosures:


Mohammad Darweesh, MD¹, Rasheed Musa, MD¹, Ratib Mahfouz, MD², Mahmoud Mansour, MD³, Adham E. Obeidat, MBBS⁴, Usama Abu-Heija, MBBS¹, Chakradhar Reddy, MD¹. D0391 - Inflammatory Bowel Disease Is a Strong Predictor of Central Line-Associated Blood Stream Infections in Patients Admitted to the ICU, ACG 2022 Annual Scientific Meeting Abstracts. Charlotte, NC: American College of Gastroenterology.